![]() ![]() "People have thought really carefully about. ![]() Allison McGeer, an infectious disease specialist at Mount Sinai Hospital in Toronto, says the recommendations from NACI were expected. ![]() The mRNA-based vaccines remain the preferred COVID-19 vaccine product, the recommendations continued.ĭr. "Manufacturers have indicated that new COVID-19 vaccine formulations are in development and products are forthcoming," Canada's vaccine advisers wrote, adding that booster doses expected for the fall will be "updated to target more recent, immune-evasive SARS-CoV-2 variants."ĭuration 2:19 The virus that causes COVID-19 continues to mutate amid reduced testing, adding to concerns that a new variant could explode before it's detected and tracked. "This additional dose is especially important for those at increased risk of COVID-19 infection or severe disease."īack in May, a World Health Organization advisory group suggested it would be ideal to focus on a monovalent shot targeting XBB.1 and its offshoots, rather than a bivalent vaccine targeting both new and old strains of the coronavirus, which was the booster last rolled out in Canada. "An additional dose using the latest vaccine formulations will be an important tool to not only build back protection against severe disease that wanes over time, but also protect against currently circulating SARS-CoV-2 variants," Canada's chief public health officer, Dr. The next round of vaccines will likely be monovalent - meaning they will specifically target the Omicron family of sub-lineages that are still circulating globally, the National Advisory Committee on Immunization (NACI) said Tuesday. The country's national vaccine advisers are recommending Canadians get another COVID-19 booster shot this fall, with updated vaccines expected in the months ahead. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |